The FDA's Cancer Revolution with Richard Pazdur_e.087

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Richard Pazdur, one of the most influential figures in modern oncology and cancer drug development. As the founding director of the FDA's Oncology Center of Excellence and former director of the Office of Hematology and Oncology Products, Richard has helped shape the regulatory pathways behind many of today's breakthrough cancer therapies while leading initiatives that have accelerated patient access to lifesaving medicines around the world.Richard reflects on his journey from growing up on Chicago's South Side to becoming a physician, researcher, and ultimately one of the most impactful leaders in the FDA's history. He shares how an unexpected career change led him into oncology, why basic science remains the foundation of every medical breakthrough, and how cancer treatment has evolved from toxic chemotherapy to targeted therapies and immunotherapy.Throughout the conversation, Richard discusses the challenges of driving innovation within government, the leadership principles that helped him establish the FDA's Oncology Center of Excellence, and the global impact of initiatives like Project Orbis and Project Facilitate. He also offers his perspective on the future of oncology, including AI, early cancer detection, international collaboration, and why continued investment in science is essential to improving patient outcomes.